Chemesis Announces Filing of Management Information Circular and Date of Special Meeting
Chemesis International Inc. (CADMF) has filed a management information circular regarding its Change of Business Transaction, initially announced on April 19, 2022. The circular is available on SEDAR. The transaction's completion is subject to approval from the Canadian Securities Exchange and the Company’s shareholders. A special meeting to discuss this transaction is scheduled for June 21, 2022. Chemesis emphasizes that forward-looking statements in the release are subject to risks and uncertainties that could impact expected outcomes.
- Management information circular filed regarding Change of Business Transaction.
- Special meeting for shareholders scheduled for June 21, 2022.
- Completion of the Change of Business Transaction is contingent upon approvals, creating uncertainty.
- Forward-looking statements may not materialize, indicating potential business risks.
VANCOUVER, British Columbia, May 25, 2022 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI, OTC PINK: CADMF, FRA: CWAA) (the “Company” or “Chemesis”) is pleased to announce that it has filed a management information circular (the “Management Information Circular”) in respect of the Company’s previously announced change of business transaction (see news release dated April 19, 2022) (the “Change of Business Transaction”). The Management Information Circular can be found on the Company’s System for Electronic Document Analysis and Retrieval (SEDAR) profile at sedar.com. The completion of the proposed Change of Business Transaction remains subject to the approvals of the Canadian Securities Exchange and the shareholders of the Company. The Company further announces that the shareholders’ special meeting in respect of the Change of Business Transaction is scheduled for June 21, 2022 (the “Special Meeting”).
On Behalf of The Board of Directors
Josh Rosenberg
President
For further information, please contact Chemesis International Inc.
Investor Relations:
ir@chemesis.com
1 (604) 398-3378
Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Change of Business Transaction, the Company's business, products and future of the Company’s business. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Change of Business Transaction will not be completed as contemplated, or at all, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release
The CSE has neither approved nor disapproved the information contained herein.
FAQ
What is the Change of Business Transaction for Chemesis International (CADMF)?
When is the special meeting for Chemesis International's Change of Business Transaction?
Where can I find the management information circular for Chemesis International (CADMF)?
What approvals are needed for the Change of Business Transaction of Chemesis (CADMF)?
